| Case Name | Date Filed | Judge | Drug | Patent No(s). |
|---|---|---|---|---|
| Gilead Sciences, Inc. v. Lupin Pharms., Inc., 15-1956 (D. Md.) | July 1, 2015 | Hon. J. Frederick Motz | Tamiflu® (oseltamivir phosphate capsules) | 5,763,483 |
| Otsuka Pharm. Co., Ltd. v. MaCleods Pharms. Ltd., 15-5109 (D.N.J.) | July 2, 2015 | Hon. Jerome B. Simandle | Abilify® (aripiprazole tablets) |
8,017,615
8,580,796
8,642,760
8,759,350
|
| Dr. Reddy’s Labs., Ltd. v. Helsinn Healthcare S.A., IPR2015-01550 (PTAB) | July 3, 2015 | N/A | Aloxi® (palonosetron hydrochloride for injection) | 8,729,094 |
| Dr. Reddy’s Labs., Ltd. v. Helsinn Healthcare S.A., IPR2015-01551 (PTAB) | July 3, 2015 | N/A | Aloxi® (palonosetron hydrochloride for injection) | 8,729,094 |
| Dr. Reddy’s Labs., Ltd. v. Helsinn Healthcare S.A., IPR2015-01553 (PTAB) | July 3, 2015 | N/A | Aloxi® (palonosetron hydrochloride for injection) | 8,729,094 |
| Dr. Reddy’s Labs., Ltd. v. Helsinn Healthcare S.A., IPR2015-01554 (PTAB) | July 3, 2015 | N/A | Aloxi® (palonosetron hydrochloride for injection) | 8,729,094 |
| Eli Lilly and Co. v. Lupin Pharms., Inc., 15-1047 (S.D. Ind.) | July 6, 2015 | Hon. Sarah Evans Barker | Axiron® (testosterone metered transdermal solution) |
8,419,307
8,177,449
8,435,944
8,807,861
8,993,520
|
| Prinston Pharm., Inc. v. Noven Therapeutics, LLC, 15-5308 (D.N.J.) | July 7, 2015 | Hon. Claire C. Cecchi | Brisdelle® (paroxetine mesylate capsules) | 8,946,251 |
| Eli Lilly and Co. v. Lupin Pharms., Inc., 15-0877 (E.D. Va.) | July 6, 2015 | Hon. Anthony J. Trenga | Axiron® (testosterone metered transdermal solution) |
8,419,307
8,177,449
8,435,944
8,807,861
8,993,520
|
| Celgene Corp. v. Teva Pharms. USA, Inc., 15-0589 (D. Del.) | July 10, 2015 | Hon. Richard G. Andrews | Istodax® (romidepsin for injection) |
7,608,280
7,611,724
|
| R-Tech Ueno, Ltd. v. Apotex, Inc., 15-0592 (D. Del.) | July 10, 2015 | Hon. Sue L. Robinson | Rescula® (unoprostone isopropyl ophthalmic solution) |
6,770,675
6,458,836
|
| Eli Lilly and Co. v. Mylan Labs. Ltd., 15-1083 (S.D. Ind.) | July 10, 2015 | Hon. Sarah Evans Barker | Alimta® (pemetrexed for injection) | 7,772,209 |
| Fresenius Kabi USA, LLC v. Cubist Pharms., Inc., IPR2015-01566 (PTAB) | July 10, 2015 | N/A | Cubicin® (daptomycin for injection) | 8,129,342 |
| Fresenius Kabi USA, LLC v. Cubist Pharms., Inc., IPR2015-01570 (PTAB) | July 10, 2015 | N/A | Cubicin® (daptomycin for injection) | 8,058,238 |
| Fresenius Kabi USA, LLC v. Cubist Pharms., Inc., IPR2015-01571 (PTAB) | July 10, 2015 | N/A | Cubicin® (daptomycin for injection) | 8,058,238 |
| Fresenius Kabi USA, LLC v. Cubist Pharms., Inc., IPR2015-01572 (PTAB) | July 10, 2015 | N/A | Cubicin® (daptomycin for injection) | 8,058,238 |
| Senju Pharm. Co., Ltd. v. Watson Labs., Inc., 15-5591 (D.N.J.) | July 16, 2015 | Hon. Jerome B. Simandle | Prolensa® (bromfenac ophthalmic solution) |
8,129,431
8,669,290
8,754,131
8,871,813
8,927,606
|
| Gilead Sciences, Inc. v. Sigmapharm Labs., LLC, 15-3950 (E.D. Pa.) | July 16, 2015 | Hon. Gerald J. Pappert | Letairis® (ambrisentan tablets) | RE42,462 |
| Meda Pharms Inc. v. Amneal Pharms. LLC, 15-0617 (D. Del.) | July 17, 2015 | Hon. Gregory M. Sleet | Astepro® (azelastine hydrochloride nasal spray) |
8,071,073
8,518,919
|
| Roxane Labs., Inc. v. Novel Labs., Inc., 15-5618 (D.N.J.) | July 17, 2015 | Hon. Stanley R. Chesler | Phoslo® (calcium acetate tablet) | 8,563,032 |
| Jazz Pharms., Inc. v. Wockhardt Bio AG, 15-5619 (D.N.J.) | July 17, 2015 | Hon. Esther Salas | Xyrem® (sodium oxybate oral solution) |
6,472,431
6,780,889
7,262,219
7,851,506
8,263,650
8,324,275
8,461,203
7,668,730
7,765,106
7,765,107
7,895,059
8,457,988
8,589,182
8,731,963
8,772,306
8,859,619
8,952,062
|
| Spectrum Pharms., Inc. v. Actavis LLC, 15-1360 (D. Nev.) | July 17, 2015 | Hon. James C. Mahan | Fusilev® (levoleucovorin calcium for injection) | 6,500,829 |
| Alcon Research, Ltd. v. Lupin Ltd., 15-0621 (D. Del.) | July 20, 2015 | Hon. Sue L. Robinson | Travatan Z® (travoprost ophthalmic solution) |
8,268,299
8,323,630
8,388,941
|
| United Therapeutics Corp. v. Watson Labs., Inc., 15-5723 (D.N.J.) | July 22, 2015 | Hon. Peter G. Sheridan | Tyvaso® (treprostinil inhalation solution) |
6,521,212
6,756,033
8,497,393
|
| Alcon Pharms. Ltd. v. Dr. Reddy’s Labs., Inc., 15-5756 (D.N.J.) | July 24, 2015 | Hon. Peter G. Sheridan | Ciprodex® (ciprofloxacin / dexamethasone otic suspension) |
6,284,804
6,359,016
|
| Lannett Holdings, Inc. v. AstraZeneca AB, IPR2015-01629 (PTAB) | July 28, 2015 | N/A | Zomig® (zolmitriptan nasal spray) | 6,750,237 |
| Lannett Holdings, Inc. v. AstraZeneca AB, IPR2015-01630 (PTAB) | July 28, 2015 | N/A | Zomig® (zolmitriptan nasal spray) | 7,220,767 |
| Mylan Pharma Acquisition LTD v. Fresenius Kabi USA, LLC, 15-6700 (N.D. Ill.) | July 30, 2015 | Hon. Rebecca R. Pallmeyer | Ultiva® (remifentanil hydrochloride for Injection) | 5,866,591 |
| Janssen Pharmaceutica N.V. v. Fera Pharms., LLC, 15-5997 (S.D.N.Y.) | July 30, 2015 | Hon. P. Kevin Castel | Sporanox® (itraconazole oral solution) | 6,407,079 |
| Cosmo Technologies Ltd. v. Lupin Ltd., 15-0669 (D. Del.) | July 31, 2015 | Hon. Leonard P. Stark | Uceris® (budesonide tablets) |
7,410,651
RE43,799
|
| Galderma Labs., L.P. v. Dr. Reddy’s Labs., Ltd., 15-0670 (D. Del.) | July 31, 2015 | Hon. Leonard P. Stark | Oracea® (doxycycline capsules) |
7,211,267
7,232,572
8,603,506
7,749,532
8,206,740
8,394,405
8,394,406
8,470,364
8,709,478
|
| BTG Int’l Ltd. v. Actavis Labs. FL, Inc., 15-5909 (D.N.J.) | July 31, 2015 | Hon. Kevin McNulty | Zytiga® (abiraterone acetate tablets) |
5,604,213
8,822,438
|
| Validus Pharms. LLC v. Aurobindo Pharma Ltd., 15-5912 (D.N.J.) | July 31, 2015 | Hon. Michael A. Shipp | Equetro® (carbamazepine extended-release capsules) | 6,977,253 |
| Sawai USA, Inc. v. Nissan Chemical Industries Ltd., IPR2015-01647 (PTAB) | July 31, 2015 | N/A | Livalo® (pitavastatin calcium tablets) | 5,856,336 |
| Sawai USA, Inc. v. Nissan Chemical Industries Ltd., IPR2015-01648 (PTAB) | July 31, 2015 | N/A | Livalo® (pitavastatin calcium tablets) | 5,856,336 |
| Janssen Biotech, Inc. v. Amneal Pharms. LLC, 15-0679 (D. Del.) | Aug. 3, 2015 | Hon. Sue L. Robinson | Zytiga® (abiraterone acetate tablets) | 8,822,438 |
| BTG International Ltd. v. Actavis Labs. FL, Inc., 15-81076 (S.D. Fla.) | Aug. 3, 2015 | Hon. Donald M. Middlebrooks | Zytiga® (abiraterone acetate tablets) |
5,604,213
8,822,438
|
| Boehringer Ingelheim Pharms. Inc. v. HEC Pharm Group, 15-5982 (D.N.J.) | Aug. 4, 2015 | Hon. Peter G. Sheridan |
Tradjenta® (linagliptin tablets)
Jentadueto® (linagliptin / metformin hydrochloride tablets)
|
7,407,955
8,119,648
8,178,541
8,673,927
8,846,695
8,853,156
|
| Janssen Biotech, Inc. v. Mylan Pharms. Inc., 15-0130 (N.D.W.V.) | Aug. 4, 2015 | Hon. Irene M. Keeley | Zytiga® (abiraterone acetate tablets) | 8,822,438 |
| Purdue Pharma L.P. v. Actavis Labs. FL, Inc., 15-0686 (D. Del.) | Aug. 5, 2015 | Hon. Gregory M. Sleet | Hysingla® ER (hydrocodone bitartrate extended-release tablets) |
6,733,783
8,361,499
8,551,520
8,647,667
9,023,401
8,529,948
8,808,740
8,309,060
|
| Purdue Pharma L.P. v. Alvogen Pine Brook, Inc., 15-0687 (D. Del.) | Aug. 5, 2015 | Hon. Gregory M. Sleet | Hysingla® ER (hydrocodone bitartrate extended-release tablets) |
6,733,783
8,361,499
8,551,520
8,647,667
9,023,401
8,529,948
8,808,740
8,309,060
|
| AstraZeneca AB v. HEC Pharm Co., Ltd., 15-6025 (D.N.J.) | Aug. 5, 2015 | Hon. Mary L. Cooper | Nexium® (esomeprazole magnesium delayed-release tablets) |
6,369,085
7,411,070
8,466,175
|
| Purdue Pharma L.P. v. Collegium Pharm., Inc., 15-13099 (D. Mass.) | Aug. 6, 2015 | Hon. F. Dennis Saylor, IV |
OxyContin® (oxycodone extended-release tablets)
Xtampza ER™ (oxycodone extended-release capsules)
|
7,674,799
7,674,800
7,683,072
8,652,497
|
| Purdue Pharm. Products L.P. v. Lannett Holdings, Inc., 15-6036 (D.N.J.) | Aug. 6, 2015 | Hon. Susan D. Wigenton | Dilaudid® (hydromorphone hydrochloride oral solution) | 6,589,960 |
| AstraZeneca Pharms. LP v. Agila Specialties, Inc., 15-6039 (D.N.J.) | Aug. 6, 2015 | Hon. Renee Marie Bumb | Faslodex® (fulvestrant injection) |
6,774,122
7,456,160
8,329,680
8,466,139
|
| Merck Sharp & Dohme Corp. v. Actavis Labs. FL, Inc., 15-6075 (D.N.J.) | Aug. 6, 2015 | Hon. Peter G. Sheridan | Noxafil® (posaconazole delayed-release tablets) | 5,661,151 |
| Collegium Pharm., Inc. v. Purdue Pharma L.P., 15-6179 (S.D.N.Y.) | Aug. 6, 2015 | Hon. Katherine B. Forrest |
OxyContin® (oxycodone extended-release tablets)
Xtampza ER™ (oxycodone extended-release capsules)
|
7,674,799
7,674,800
7,683,072
8,652,497
|
| Eli Lilly and Co. v. Emcure Pharms Ltd., 15-1244 (S.D. Ind.) | Aug. 7, 2015 | Hon. Jane Magnus-Stinson | Alimta® (pemetrexed for injection) | 7,772,209 |
| AstraZeneca AB v. Lupin Ltd., 15-6092 (D.N.J.) | Aug. 7, 2015 | Hon. Mary L. Cooper | Nexium 24HR® (esomeprazole magnesium delayed-release capsules) |
6,369,085
7,411,070
|
| Coalition for Affordable Drugs VII LLC v. Pozen Inc., IPR2015-01680 (PTAB) | Aug. 7, 2015 | N/A | Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) | 8,852,636 |
| Hospira, Inc. v. Amneal Pharms. LLC, 15-0697 (D. Del.) | Aug. 11, 2015 | Hon. Richard G. Andrews | Precedex® (dexmedetomidine hydrochloride injection) |
8,242,158
8,338,470
8,455,527
8,648,106
|
| Par Pharm., Inc. v. TWi Pharms., Inc., 15-0698 (D. Del.) | Aug. 11, 2015 | Hon. Sue L. Robinson | Megace® ES (megestrol acetate oral suspension) |
9,101,540
9,101,549
|
| Boehringer Ingelheim Pharms. Inc. v. Intas Pharms., Ltd., 15-0664 (M.D.N.C.) | Aug. 11, 2015 | Hon. Catherine C. Eagles | Jentadueto® (linagliptin / metformin hydrochloride tablets) |
8,673,927
8,846,695
|
| Horizon Pharma Ireland Ltd v. Actavis Labs. UT, Inc., 15-6131 (D.N.J.) | Aug. 11, 2015 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) | 9,101,591 |
| Horizon Pharma Ireland Ltd v. Amneal Pharms. LLC, 15-6132 (D.N.J.) | Aug. 11, 2015 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) | 9,101,591 |
| Horizon Pharma Ireland Ltd v. IGI Labs., Inc., 15-6134 (D.N.J.) | Aug. 11, 2015 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) | 9,101,591 |
| Horizon Pharma Ireland Ltd v. Taro Pharms. USA, Inc., 15-6135 (D.N.J.) | Aug. 11, 2015 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) | 9,101,591 |
| Coalition for Affordable Drugs VII LLC v. Horizon Pharma USA, Inc., IPR2015-01718 (PTAB) | Aug. 12, 2015 | N/A | Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) | 8,945,621 |
| Millennium Pharms., Inc. v. Pharmascience Inc., 15-0702 (D. Del.) | Aug. 13, 2015 | Hon. Gregory M. Sleet | Velcade® (bortezomib for injection) |
6,713,446
6,958,319
|
| Coalition for Affordable Drugs IX LLC v. Bristol-Myers Squibb Co., IPR2015-01723 (PTAB) | Aug. 13, 2015 | N/A | Eliquis® (apixaban tablets) | 6,967,208 |
| Noven Therapeutics, LLC v. Actavis Labs. FL, Inc., 15-6225 (D.N.J.) | Aug. 14, 2015 | Hon. Claire C. Cecchi | Brisdelle® (paroxetine mesylate capsules) | 8,946,251 |
| Vivus, Inc. v. Actavis Labs. FL, Inc., 15-6256 (D.N.J.) | Aug. 17, 2015 | Hon. Stanley R. Chesler | Qsymia® (phentermine / topiramate extended-release capsules) |
9,011,905
9,011,906
|
| Par Pharm., Inc. v. TWi Pharms., Inc., 15-0710 (D. Del.) | Aug. 18, 2015 | Hon. Sue L. Robinson | Megace® ES (megestrol acetate oral suspension) | 9,107,827 |
| Dr. Reddy’s Labs., Inc. v. Fresenius Kabi USA, LLC, 15-0714 (D. Del.) | Aug. 18, 2015 | Hon. Richard G. Andrews | Diprivan® (propofol injectable emulsion) | 8,476,010 |
| Lupin Ltd. v. Pozen, Inc., IPR2015-01773 (PTAB) | Aug. 19, 2015 | N/A | Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) | 8,858,996 |
| Lupin Ltd. v. Pozen, Inc., IPR2015-01774 (PTAB) | Aug. 19, 2015 | N/A | Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) | 8,852,636 |
| Lupin Ltd. v. Pozen, Inc., IPR2015-01775 (PTAB) | Aug. 19, 2015 | N/A | Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) | 8,865,190 |
| Coalition for Affordable Drugs X LLC v. Anacor Pharms., Inc., IPR2015-01776 (PTAB) | Aug. 20, 2015 | N/A | Kerydin® (Tavaborole topical solution) | 7,582,621 |
| Dr. Reddy’s Labs., Ltd. v. Galderma Labs., Inc., IPR2015-01777 (PTAB) | Aug. 20, 2015 | N/A | Oracea® (doxycycline capsules) | 8,603,506 |
| Dr. Reddy’s Labs., Ltd. v. Galderma Labs., Inc., IPR2015-01778 (PTAB) | Aug. 20, 2015 | N/A | Oracea® (doxycycline capsules) | 8,603,506 |
| Coalition for Affordable Drugs X LLC v. Anacor Pharms., Inc., IPR2015-01780 (PTAB) | Aug. 20, 2015 | N/A | Kerydin® (Tavaborole topical solution) | 7,767,657 |
| Dr. Reddy’s Labs., Ltd. v. Galderma Labs., Inc., IPR2015-01782 (PTAB) | Aug. 20, 2015 | N/A | Oracea® (doxycycline capsules) | 8,603,506 |
| Coalition for Affordable Drugs X LLC v. Anacor Pharms., Inc., IPR2015-01785 (PTAB) | Aug. 20, 2015 | N/A | Kerydin® (Tavaborole topical solution) | 7,767,657 |
| Merck Sharp & Dohme Corp. v. Savior Lifetec Corp., 15-0415 (E.D.N.C.) | Aug. 21, 2015 | Hon. Terrence W. Boyle | Invanz® (ertapenem for injection) | 5,952,323 |
| Otsuka Pharm. Co., Ltd. v. Standard Chem. & Pharm. Co., Ltd., 15-6353 (D.N.J.) | Aug. 21, 2015 | Hon. Jerome B. Simandle | Abilify® (aripiprazole tablets) |
8,017,615
8,580,796
8,642,760
8,759,350
|
| Sumitomo Dainippon Pharma Co., Ltd. v. Teva Pharms. USA, Inc., 15-6401 (D.N.J.) | Aug. 24, 2015 | Hon. Stanley R. Chesler | Latuda® (lurasidone hydrochloride tablets) | 5,532,372 |
| Allergan Inc, v. Teva Pharms. USA, Inc., 15-1455 (E.D. Tex.) | Aug. 24, 2015 | Hon. Rodney Gilstrap | Restasis® (cyclosporine ophthalmic emulsion) |
8,629,111
8,633,162
8,642,556
8,648,048
8,685,930
|
| Coalition for Affordable Drugs XI LLC v. Insys Pharma, Inc., IPR2015-01797 (PTAB) | Aug. 24, 2015 | N/A | Subsys® (fentanyl sublingual spray) | 8,835,459 |
| Coalition for Affordable Drugs XI LLC v. Insys Pharma, Inc., IPR2015-01799 (PTAB) | Aug. 24, 2015 | N/A | Subsys® (fentanyl sublingual spray) | 8,835,460 |
| Coalition for Affordable Drugs XI LLC v. Insys Pharma, Inc., IPR2015-01800 (PTAB) | Aug. 24, 2015 | N/A | Subsys® (fentanyl sublingual spray) | 8,486,972 |
| Cephalon, Inc. v. Panacea Biotec, Ltd., 15-0735 (D. Del.) | Aug. 25, 2015 | Hon. Sue L. Robinson | Treanda® (bendamustine hydrochloride for infusion) |
8,445,524
8,791,270
8,669,279
8,883,836
8,895,756
|
| Boehringer Ingelheim Pharms. Inc. v. Mylan Pharms., Inc., 15-0145 (N.D.W.V.) | Aug. 25, 2015 | Hon. John Preston Bailey |
Tradjenta® (linagliptin tablets)
Jentadueto® (linagliptin / metformin hydrochloride tablets)
|
8,673,927
8,846,695
8,853,156
|
| The Medicines Co. v. Sagent Pharms., Inc., 15-7507 (N.D. Ill.) | Aug. 26, 2015 | Hon. Harry D. Leinenweber | Angiomax® (bivalirudin for injection) |
7,582,727
7,598,343
|
| Amneal Pharms. LLC v. Jazz Pharms., Inc., IPR2015-01810 (PTAB) | Aug. 26, 2015 | N/A | Xyrem® (sodium oxybate oral solution) | 7,895,059 |
| Amneal Pharms. LLC v. Jazz Pharms., Inc., IPR2015-01817 (PTAB) | Aug. 26, 2015 | N/A | Xyrem® (sodium oxybate oral solution) | 8,457,988 |
| Forest Labs., LLC v. Amneal Pharms. LLC, 15-0756 (D. Del.) | Aug. 27, 2015 | Hon. Leonard P. Stark | Namzaric® (memantine hydrochloride / donepezil hydrochloride extended-release capsules) |
8,039,009
8,058,291
8,168,209
8,173,708
8,283,379
8,293,794
8,329,752
8,338,485
8,338,486
8,362,085
8,580,858
8,598,233
|
| Wockhardt Bio AG v. Jazz Pharms., Inc., IPR2015-01813 (PTAB) | Aug. 27, 2015 | N/A | Xyrem® (sodium oxybate oral solution) | 8,589,182 |
| Wockhardt Bio AG v. Jazz Pharms., Inc., IPR2015-01814 (PTAB) | Aug. 27, 2015 | N/A | Xyrem® (sodium oxybate oral solution) | 8,457,988 |
| Wockhardt Bio AG v. Jazz Pharms., Inc., IPR2015-01815 (PTAB) | Aug. 27, 2015 | N/A | Xyrem® (sodium oxybate oral solution) | 7,765,106 |
| Wockhardt Bio AG v. Jazz Pharms., Inc., IPR2015-01816 (PTAB) | Aug. 27, 2015 | N/A | Xyrem® (sodium oxybate oral solution) | 7,895,059 |
| Wockhardt Bio AG v. Jazz Pharms., Inc., IPR2015-01818 (PTAB) | Aug. 27, 2015 | N/A | Xyrem® (sodium oxybate oral solution) | 7,668,730 |
| Wockhardt Bio AG v. Jazz Pharms., Inc., IPR2015-01820 (PTAB) | Aug. 27, 2015 | N/A | Xyrem® (sodium oxybate oral solution) | 7,765,107 |
| Warner Chilcott (US), LLC v. Teva Pharms. USA, Inc., 15-1471 (E.D. Tex.) | Aug. 28, 2015 | Hon. Rodney Gilstrap | Delzicol® (mesalamine delayed-release capsules) | 6,649,180 |
| Galderma Labs., L.P. v. Taro Pharms. U.S.A., Inc., 15-2814 (N.D. Tex.) | Aug. 28, 2015 | Hon. Ed Kinkeade | Epiduo® (adapalene /benzoyl peroxide gel) |
8,071,644
8,080,537
8,129,362
8,445,543
8,809,305
|
| Coalition for Affordable Drugs VIII LLC v. The Trustees of The University of Pennsylvania, IPR2015-01835 (PTAB) | Aug. 28, 2015 | N/A | Juxtapid® (lomitapide mesylate capsules) | 8,618,135 |
| Coalition for Affordable Drugs VIII LLC v. The Trustees of The University of Pennsylvania, IPR2015-01836 (PTAB) | Aug. 28, 2015 | N/A | Juxtapid® (lomitapide mesylate capsules) | 7,932,268 |
| Janssen Pharmaceutica, N.V. v. Mylan Pharms., Inc., 15-0760 (D. Del.) | Aug. 31, 2015 | Hon. Sue L. Robinson | Complera® (emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate tablets) |
8,841,310
7,125,879
8,101,629
|
| Warner Chilcott (US), LLC v. Teva Pharms. USA, Inc., 15-0761 (D. Del.) | Aug. 31, 2015 | Hon. Gregory M. Sleet | Delzicol® (mesalamine delayed-release capsules) | 6,649,180 |
| Merck Sharp & Dohme Corp. v. Actavis Labs. FL, Inc., 15-6541 (D.N.J.) | Aug. 31, 2015 | Hon. William H. Walls | Dificid® (fidaxomicin tablets) |
7,906,489
8,586,551
7,378,508
7,863,249
8,859,510
|
| Gilead Sciences, Inc. v. Mylan Inc., 15-0149 (N.D.W.V.) | Aug. 31, 2015 | Hon. Irene M. Keeley | Complera® (emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate tablets) |
6,642,245
6,703,396
8,592,397
8,716,264
|
| Jazz Pharms., Inc. v. Lupin Ltd., 15-6548 (D.N.J.) | Sept. 1, 2015 | Hon. Esther Salas | Xyrem® (sodium oxybate oral solution) |
6,472,431
6,780,889
7,262,219
7,851,506
8,263,650
8,324,275
8,461,203
7,668,730
7,765,106
7,765,107
7,895,059
8,457,988
8,589,182
8,731,963
8,772,306
8,859,619
8,952,062
9,050,302
|
| Osi Pharms., LLC v. Apotex Inc., 15-0772 (D. Del.) | Sept. 2, 2015 | Hon. Sue L. Robinson | Tarceva® (erlotinib hydrochloride tablets) | 6,900,221 |
| Merck Sharp & Dohme Corp. v. Actavis Labs. FL, Inc., 15-61858 (S.D. Fla.) | Sept. 2, 2015 | Hon. Kathleen M. Williams | Dificid® (fidaxomicin tablets) |
7,906,489
8,586,551
7,378,508
7,863,249
8,859,510
|
| Omeros Corp. v. Par Sterile Products, LLC, 15-6561 (D.N.J.) | Sept. 2, 2015 | Hon. Jose L. Linares | Omidria® (phenylephrine / ketorolac injection) |
8,173,707
8,586,633
9,066,856
|
| Jazz Pharms., Inc. v. Amneal Pharms. LLC, 15-6562 (D.N.J.) | Sept. 2, 2015 | Hon. Esther Salas | Xyrem® (sodium oxybate oral solution) | 9,050,302 |
| AstraZeneca AB v. Alkem Labs. Ltd., 15-6609 (D.N.J.) | Sept. 2, 2015 | Hon. Mary L. Cooper | Nexium® (esomeprazole magnesium delayed-release capsules) |
6,369,085
7,411,070
8,466, 175
|
| AstraZeneca AB v. Actavis Elizabeth LLC, 15-6610 (D.N.J.) | Sept. 2, 2015 | Hon. Mary L. Cooper | Nexium 24HR® (esomeprazole magnesium delayed-release capsules) |
6,369,085
7,411,070
|
| Janssen Pharmaceutica, N.V. v. Mylan Pharms., Inc., 15-0152 (N.D.W.V.) | Sept. 2, 2015 | Hon. Irene M. Keeley | Complera® (emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate tablets) |
8,841,310
7,125,879
8,101,629
|
| Coalition for Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc., IPR2015-01850 (PTAB) | Sept. 2, 2015 | N/A | Ampyra® (dalfampridine extended-release tablets) | 8,440,703 |
| Coalition for Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc., IPR2015-01853 (PTAB) | Sept. 2, 2015 | N/A | Ampyra® (dalfampridine extended-release tablets) | 8,007,826 |
| Coalition for Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc., IPR2015-01857 (PTAB) | Sept. 2, 2015 | N/A | Ampyra® (dalfampridine extended-release tablets) | 8,663,685 |
| Coalition for Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc., IPR2015-01858 (PTAB) | Sept. 2, 2015 | N/A | Ampyra® (dalfampridine extended-release tablets) | 8,354,437 |
| Omeros Corp. v. Par Sterile Products, LLC, 15-0773 (D. Del.) | Sept. 3, 2015 | Hon. Richard G. Andrews | Omidria® (phenylephrine / ketorolac injection) |
8,173,707
8,586,633
9,066,856
|
| Spectrum Pharms., Inc. v. Amneal Pharms. LLC, 15-1697 (D. Nev.) | Sept. 3, 2015 | Hon. James C. Mahan | Fusilev® (levoleucovorin calcium for injection) | 6,500,829 |
| Purdue Pharma L.P. v. Alvogen Pine Brook, Inc., 15-0784 (D. Del.) | Sept. 4, 2015 | Hon. Gregory M. Sleet | Hysingla® ER (hydrocodone bitartrate extended-release tablets) |
9,056,052
9,060,940
|
| Lupin Ltd. v. Senju Pharm. Co., Ltd., IPR2015-01871 (PTAB) | Sept. 4, 2015 | N/A | Prolensa® (bromfenac ophthalmic solution) | 8,129,431 |
| Allergan, Inc. v. Innopharma, Inc., 15-1504 (E.D. Tex.) | Sept. 8, 2015 | Hon. Rodney Gilstrap | Restasis® (cyclosporine ophthalmic emulsion) |
8,629,111
8,633,162
8,642,556
8,648,048
8,685,930
|
| Meda Pharms. Inc. v. Teva Pharms. USA, Inc., 15-0785 (D. Del.) | Sept. 8, 2015 | Hon. Leonard P. Stark | Dymista® (azelastine hydrochloride / fluticasone propionate nasal spray) |
8,163,723
8,168,620
|
| Millennium Pharms., Inc. v. Hospira, Inc., 15-0804 (D. Del.) | Sept. 10, 2015 | Hon. Richard G. Andrews | Velcade® (bortezomib for injection) |
6,713,446
6,958,319
|
| Janssen Pharmaceutica N.V. v. Apotex Inc., 15-7121 (S.D.N.Y.) | Sept. 10, 2015 | Hon. William H. Pauley, III | Sporanox® (itraconazole oral solution) | 6,407,079 |
| Kowa Co., Ltd. v. Zydus Pharms. (USA) Inc., 15-7136 (S.D.N.Y.) | Sept. 10, 2015 | Hon. Paul A. Crotty | Livalo® (pitavastatin calcium tablets) | 6,465,477 |
| Merck Sharp & Dohme B.V. v. Teva Pharms. USA, Inc., 15-0806 (D. Del.) | Sept. 11, 2015 | Hon. Gregory M. Sleet | NuvaRing® (ethinyl estradiol / etonogestrel vaginal ring) | 5,989,581 |
| Kowa Co., Ltd. v. Zydus Pharms. (USA) Inc., 15-6792 (D.N.J.) | Sept. 11, 2015 | Hon. Freda L. Wolfson | Livalo® (pitavastatin calcium tablets) | 6,465,477 |
| Depomed, Inc. v. Actavis Elizabeth LLC, 15-6797 (D.N.J.) | Sept. 11, 2015 | Hon. Claire C. Cecchi | Nucynta® ER (tapentadol hydrochloride extended-release tablets) | 8,536,130 |
| Allergan Inc, v. Teva Pharms. USA, Inc., 15-0815 (D. Del.) | Sept. 14, 2015 | Hon. Sue L. Robinson | Restasis® (cyclosporine ophthalmic emulsion) |
8,629,111
8,633,162
8,642,556
8,648,048
8,685,930
|
| Amneal Pharms. LLC v. Jazz Pharms., Inc., IPR2015-01903 (PTAB) | Sept. 14, 2015 | N/A | Xyrem® (sodium oxybate oral solution) | 8,731,963 |
| Otsuka Pharm. Co., Ltd. v. Hetero USA Inc., 15-0822 (D. Del.) | Sept. 15, 2015 | Hon. Richard G. Andrews | Samsca® (tolvaptan tablets) | 5,753,677 |
| Acorda Therapeutics, Inc. v. Par Pharm., Inc., 15-0824 (D. Del.) | Sept. 15, 2015 | Hon. Leonard P. Stark | Ampyra® (dalfampridine extended-release tablets) |
8,007,826
8,354,437
8,440,703
8,663,685
|
| Gilead Sciences, Inc. v. Lupin Pharms., Inc., 15-2793 (D. Md.) | Sept. 16, 2015 | Hon. J. Frederick Motz | Tamiflu® (oseltamivir phosphate capsules) | 5,763,483 |
| Purdue Pharma L.P. v. Amneal Pharms. LLC, 15-0831 (D. Del.) | Sept. 17, 2015 | Hon. Sue L. Robinson | OxyContin® (oxycodone extended-release tablets) |
9,060,976
9,034,376
|
| Impax Labs., Inc. v. Actavis Labs. FL, Inc., 15-6934 (D.N.J.) | Sept. 17, 2015 | Hon. Katharine S. Hayden | Rytary® (levodopa / carbidopa capsules) |
7,094,427
8,377,474
8,454,998
8,557,283
9,089,607
9,089,608
|
| Horizon Pharma Ireland Ltd. v. Lupin Ltd., 15-6935 (D.N.J.) | Sept. 17, 2015 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) | 9,132,110 |
| Horizon Pharma Ireland Ltd. v. Actavis Labs. UT, Inc., 15-6989 (D.N.J.) | Sept. 17, 2015 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) | 9,132,110 |
| Horizon Pharma Ireland Ltd. v. Amneal Pharms. LLC, 15-6990 (D.N.J.) | Sept. 17, 2015 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) | 9,132,110 |
| Horizon Pharma Ireland Ltd. v. IGI Labs., Inc., 15-6991 (D.N.J.) | Sept. 17, 2015 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) | 9,132,110 |
| Bayer Pharma AG v. alembic Pharms. Ltd., 15-0832 (D. Del.) | Sept. 18, 2015 | Hon. Gregory M. Sleet | Staxyn® (vardenafil hydrochloride tablets) | 8,613,950 |
| Vivus, Inc. v. Teva Pharms. USA, Inc., 15-6957 (D.N.J.) | Sept. 18, 2015 | Hon. Stanley R. Chesler | Qsymia® (phentermine / topiramate extended-release capsules) |
9,011,905
9,011,906
|
| AstraZeneca Pharms. LP v. Mylan Pharms. Inc., 15-7009 (D.N.J.) | Sept. 21, 2015 | Hon. Renee Marie Bumb | Faslodex® (fulvestrant injection) |
6,774,122
7,456,160
8,329,680
8,466,139
|
| Astellas Pharma Inc. v. Apotex Inc., 15-0857 (D. Del.) | Sept. 22, 2015 | Hon. Sue L. Robinson | Mycamine® (micafungin sodium for injection) |
6,107,458
6,774,104
|
| Taro Pharms. U.S.A., Inc. v. Perrigo UK Finco Ltd., 15-0859 (D. Del.) | Sept. 22, 2015 | Hon. Richard G. Andrews | Topicort® (desoximetasone topical spray) |
8,277,780
8,715,624
|
| Helsinn Healthcare S.A. v. Fresenius Kabi USA, LLC, 15-7015 (D.N.J.) | Sept. 23, 2015 | Hon. Mary L. Cooper | Aloxi® (palonosetron hydrochloride for injection) |
7,947,724
7,947,725
7,960,424
8,598,219
8,729,094
|
| Helsinn Healthcare S.A. v. Fresenius Kabi USA, LLC, 15-0865 (D. Del.) | Sept. 24, 2015 | Hon. Gregory M. Sleet | Aloxi® (palonosetron hydrochloride for injection) |
7,947,724
7,947,725
7,960,424
8,598,219
8,729,094
|
| Amneal Pharms. LLC v. Yeda Research and Development Co., Ltd., IPR2015-01976 (PTAB) | Sept. 25, 2015 | N/A | Copaxone® (glatiramer acetate for injection) | 8,232,250 |
| Amneal Pharms. LLC v. Yeda Research and Development Co., Ltd., IPR2015-01980 (PTAB) | Sept. 25, 2015 | N/A | Copaxone® (glatiramer acetate for injection) | 8,399,413 |
| Amneal Pharms. LLC v. Yeda Research and Development Co., Ltd., IPR2015-01981 (PTAB) | Sept. 25, 2015 | N/A | Copaxone® (glatiramer acetate for injection) | 8,969,302 |
| Coalition For Affordable Drugs V LLC v. Biogen MA, Inc., IPR2015-01993 (PTAB) | Sept. 28, 2015 | N/A | Tecfidera® (dimethyl fumarate delayed-release capsule) | 8,399,514 |
| Mylan Pharms. Inc. v. 3M Co., IPR2015-02002 (PTAB) | Sept. 29, 2015 | N/A |
Ventolin HFA® (albuterol sulfate inhalator)
Flovent HFA® (fluticasone propionate inhalator)
Advair HFA® (fluticasone propionate / salmeterol xinafoate inhalator)
|
6,743,413 |
| Salix Pharms., Inc. v. Apotex, Inc., 15-0880 (D. Del.) | Sept. 30, 2015 | Hon. Gregory M. Sleet | Giazo® (balsalazide disodium tablets) |
6,197,341
8,497,256
|
